Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v3-EN
Language French English
Date Updated 2023-11-17 2023-05-02
Drug Identification Number 02500272 02500272
Brand name KYNMOBI KYNMOBI
Common or Proper name Apomorphine HCl soluble film Apomorphine HCl soluble film
Company Name SUNOVION PHARMACEUTICALS CANADA INC SUNOVION PHARMACEUTICALS CANADA INC
Ingredients APOMORPHINE HYDROCHLORIDE APOMORPHINE HYDROCHLORIDE
Strength(s) 15MG 15MG
Dosage form(s) FILM, SOLUBLE FILM, SOLUBLE
Route of administration SUBLINGUAL SUBLINGUAL
Packaging size Cartons of 30 films Cartons of 30 films
ATC code N04BC N04BC
ATC description
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2023-09-30 2023-09-30
Actual discontinuation date 2023-09-29
Remaining supply date 2025-03-31 2025-03-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status Yes No
Information on remaining supply
Company comments 1-888-363-0205 or csrsunovion@accuristix.com
Health Canada comments